Anti-CD30 monoclonal antibody-saporin conjugate

Drug Profile

Anti-CD30 monoclonal antibody-saporin conjugate

Alternative Names: Ber-H2/Saporin; Ber-H2/SO6 immunotoxin; Monoclonal antibody Ber-H2-SO6 conjugate

Latest Information Update: 22 Dec 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Drug conjugates; Immunoconjugates; Immunotoxins; Monoclonal antibodies
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 22 Dec 1998 No-Development-Reported for Cancer in Italy (Unknown route)
  • 15 May 1997 Preclinical development for Cancer in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top